Despite it being well established that heterozygous mutations in BRCA1 predispose women to develop breast and ovarian cancer at a very early age, only recently was it discovered that biallelic mutations in BRCA1 cause a FA-like neurodevelopmental disorder designated complementation group S (FANCS). This evidence concerns the gene BRCA1 and ovarian carcinoma.